Complete Response of Triple-Negative Metaplastic Carcinoma of the Breast Using Pembrolizumab

Metaplastic breast cancer (MpBC) is a rare form of breast malignancy with a poor prognosis and limited treatment guidance. Here, we report on a case of triple-negative MpBC that was successfully treated following the Keynote-522 clinical algorithm using pembrolizumab, paclitaxel, carboplatin, adriam...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladwa, Amrita, Elghawy, Omar, Schroen, Anneke, Abernathy, Kristan, Schlefman, Jenna, Dillon, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601781/
https://www.ncbi.nlm.nih.gov/pubmed/37900847
http://dx.doi.org/10.1159/000534146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601781/
https://www.ncbi.nlm.nih.gov/pubmed/37900847
http://dx.doi.org/10.1159/000534146

Ejemplares similares